BofA Securities stays Buy on Ionis Pharmaceuticals (IONS) as new pricing 'a positive update'
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry reiterated a Buy rating and $100.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
